Article Text
Abstract
Newborn screening programmes began in the 1960s, have traditionally been conducted without parental permission and have grown dramatically in the last decade. Whether these programmes serve patients’ best interests has recently become a point of controversy. Privacy advocates, concerned that newborn screening infringes upon individual liberties, are demanding fundamental changes to these programmes. These include parental permission and limiting the research on the blood samples obtained, an agenda at odds with the viewpoints of newborn screening advocates. This essay presents the history of newborn screening in the USA, with attention to factors that have contributed to concerns about these programmes. The essay suggests that the rapid increase in the number of disorders screened for and the addition of research without either public knowledge or informed consent were critical to the development of resistance to mandatory newborn screening and research. Future newborn screening initiatives should include public education and comment to ensure continued support.
- Confidentiality/Privacy
- Genetic Screening/Testing
- Public Health Ethics
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry
- Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies
- Newborn screening for medium chain acyl CoA dehydrogenase deficiency
- Diagnostic potential of stored dried blood spots for inborn errors of metabolism: a metabolic autopsy of medium-chain acyl-CoA dehydrogenase deficiency
- Newborn and childhood screening programmes: criteria, evidence, and current policy
- Screening for MCAD deficiency in newborns
- Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK
- New developments in neonatal screening
- Processing of positive newborn screening results: a qualitative exploration of current practice in England
- Ethical issues in predictive genetic testing: a public health perspective